ANP Antibodies

Santa Cruz Biotechnology features a diverse variety of ANP Antibodies for understanding the role of Atrial Natriuretic Peptide (ANP) in various physiological processes. Monoclonal ANP Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ANP is a crucial hormone involved in the regulation of blood pressure, fluid balance, and electrolyte homeostasis. It is primarily secreted by the heart's atrial cells in response to increased blood volume and pressure, playing a significant role in cardiovascular health. The study of ANP and its signaling pathways is essential for understanding various cardiac conditions and developing potential therapeutic strategies. ANP research has revealed important insights into cardiovascular disease mechanisms and potential treatment approaches. Ongoing investigations continue to uncover new functions and regulatory pathways associated with ANP in different physiological systems. Research utilizing ANP has contributed significantly to our understanding of heart failure, hypertension, and other cardiovascular disorders. Santa Cruz Biotechnology monoclonal ANP antibodies support researchers worldwide in advancing cardiovascular research and therapeutic development.